# VFF earnings call intelligence

LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/VFF) · [Earnings tab](https://www.lopjlb.com/stock/VFF?tab=earnings)

Updated: 2026-08-10T02:27:52

Quarters analyzed: 8

## Cross-quarter narrative

Across eight quarterly CallCards from Q2 2024 to Q1 2026, Village Farms (VFF) moved from a record‑setting sales quarter tempered by US regulatory frustration and heavy excise taxes to a period of accelerating profitability and geographic expansion. Early calls highlighted strong Canadian cannabis market‑share gains, fresh‑produce volume growth and the start‑up of the Netherlands cultivation facility, while noting vague guidance and pricing pressure. By Q4 2024 the company posted double‑digit revenue growth, a sizable inventory write‑down and a 113 % jump in medical exports, setting the stage for a cash‑generating joint‑venture that privatized the fresh‑produce division in Q1 2025. That quarter also revealed operational headwinds – dust storms in Texas – and a suite of regulatory and execution risks. Subsequent quarters showed dramatic upside: a 700 % surge in cannabis exports, Delta‑2 conversion approval for 40 MT capacity, record adj‑EBITDA margins, and a $10 M share‑buyback program. International export growth accelerated (6‑fold in 2025) and the Netherlands Phase 1 reached capacity, while Phase 2 and Delta‑2 expansions remained on track. A BC labor strike briefly dented Q4 2025 results, but cash flow stayed robust. By Q1 2026 VFF emphasized disciplined M&A after US rescheduling, continued export momentum and pending certification of Groningen Phase 2, underscoring a trajectory of margin improvement and capacity scaling despite lingering operational and regulatory frictions.

## Latest CallCard · Q1

VFF Q1 2026: 27% sales growth, 118% adj EBITDA growth, record $15M international exports, Delta 2 expansion on track, Groningen Phase 2 awaiting certification, disciplined M&A approach post-US rescheduling.','tone': {'mgmt': 0.3, 'mgmt_rationale': 'Prepared remarks emphasize strong Q1 results, recor

**Guidance:** vague

**Tone:** mgmt 0 · Q&A pressure 0 · divergence 0

## Quarter one-liners

- **2026 Q1:** VFF Q1 2026: 27% sales growth, 118% adj EBITDA growth, record $15M international exports, Delta 2 expansion on track, Groningen Phase 2 awaiting certification, disciplined M&A approach post-US rescheduling.','tone': {'mgmt': 0.3, 'mgmt_rationale': 'Prepared remarks emphasize strong Q1 results, recor
- **2025 Q4:** VFF delivered record 2025 profitability ($21M net income, $50M adj EBITDA, $58M cash flow) driven by 17% cannabis sales growth and 6x export growth; Q4 impacted by BC labor strike (-$2.5M) and export timing; Delta 2 and Netherlands expansions on track; share buybacks active.','tone': {'mgmt': 0.7, '
- **2025 Q3:** VFF delivered record Q3 with 21% sales growth, 31% adj EBITDA margin, $24.4M operating cash flow; Canadian cannabis gross margin 56%, international exports up 758%; expanding capacity in Canada and Netherlands; $10M share buyback authorized.','tone': {'mgmt': 0.8, 'mgmt_rationale': 'CEO emphasized r
- **2025 Q2:** VFF Q2 2025: record profitability, produce privatization yields $40M cash, cannabis exports surge 700%, Delta 2 conversion approved for 40MT capacity by 2027. Net income $9.9M, adj EBITDA $17.1M (28.6% margin). International exports hit full-year target at H1. Netherlands Phase 1 at capacity, Phase 
- **2025 Q1:** Village Farms announced a $40M cash JV to privatize its fresh produce division, saw cannabis margin expansion to 36%, but fresh produce was hit by dust storms, while Netherlands expansion proceeds.
- **2024 Q4:** VFF Q4 revenue $83M (+11% YoY), FY $336M (+18%); Canadian cannabis organic sales +31%, market share leader; $10.5M inventory write-down masks strong underlying EBITDA; international medical exports +113% YoY, targeting 3x growth in 2025; Netherlands Phase 2 expansion underway; fresh produce margins 
- **2024 Q3:** VFF Q3: Fresh Produce sales +20%, Canadian cannabis +29% organic, #1 in Ontario/Quebec, positive adj EBITDA both segments; Netherlands cultivation started, first sales Q1'25; holding Canada CapEx due to excise tax, bullish on Europe/US rescheduling.','tone': {'mgmt': 0.5, 'mgmt_rationale': 'CEO high
- **2024 Q2:** VFF posts record Q2 sales driven by Canadian cannabis market share gains and fresh produce volume growth; Netherlands facility on track for Q1 2025 sales; US regulatory frustration persists; produce pricing pressure limits full-year breakeven. Excise tax burden remains heavy. Cash flow positive, sel

## Theme arcs

- **Cannabis margin expansion** (improving): Gross margin rose from 25% to 56% between 2025 Q1 and Q5 Q3
- **International export growth** (improving): Exports grew 113% YoY in 2024 Q4, 700% in 2025 Q2 and 6‑x in 2025 overall
- **Netherlands capacity build‑out** (improving): Phase 1 delivered and at capacity; Phase 2 on track through 2025‑26
- **Fresh‑produce volatility** (deteriorating): Dust storms in Texas raised costs 31% and remain at risk
- **US regulatory frustration** (stable): Persisted from 2024 Q2 with no resolution
- **Excise‑tax burden in Canada** (stable): Heavy tax impact noted early and never resolved
- **Capital actions (JV, buybacks)** (new): $40 M JV cash in 2025 Q1 and $10 M buyback authorized in 2025 Q3
- **Labor unrest** (new): BC strike impacted Q4 2025 earnings
- **Delta‑2 expansion** (improving): Conversion approved 2025 Q2 and on track through 2026
- **M&A discipline post‑US rescheduling** (new): Emphasized in 2026 Q1

## Fear persistence

- **Operational – dust storms** [recurring]: Cost surge in Texas noted Q1 2025, mitigation still at risk
- **Regulatory – US hemp bans** [recurring]: State‑level bans cited Q1 2025, no update
- **Regulatory – US cannabis rescheduling frustration** [recurring]: Mentioned Q2 2024, persists through later calls
- **Tax – Canadian excise burden** [recurring]: Heavy excise tax noted Q2 2024, unchanged
- **Execution – Vanguard JV closing** [recurring]: Closing required Q2 2025, no later resolution
- **Market – Canadian non‑branded pricing volatility** [recurring]: Pricing risk flagged Q1 2025
- **Currency – USD strength impact** [recurring]: Reduced CAD‑reported cannabis revenue Q1 2025
- **Labor – BC strike** [new]: Strike impacted Q4 2025 earnings

## Guidance path

2024 Q2:vague → 2024 Q3:vague → 2024 Q4:vague → 2025 Q1:maintained → 2025 Q2:vague → 2025 Q3:vague → 2025 Q4:vague → 2026 Q1:vague

---

Research context only. Not personalized investment advice.

API: `GET /bff/api/bigfive/earnings-intel/VFF`